The Effect of quadratus lumborum block for controlling pain in childrens undergoing renal transplant surgery

The effect of posterior quadratus lumborum block for intra and post operative analgesia in pediatric patients undergoing renal transplant surgery-a pilot study - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/074599

Enrollment

Registered

2024-10-01

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N261- Atrophy of kidney (terminal) Health Condition 2: N185- Chronic kidney disease, stage 5 Health Condition 3: N189- Chronic kidney disease, unspecified Health Condition 4: N258- Other disorders resulting from impaired renal tubular function Health Condition 5: N19- Unspecified kidney failure

Interventions

Intervention1: Quadratus Lumborum block: 0.5ml/kg of 0.2% Ropivacaine through posterior part of QL muscle given once before start of surgery Control Intervention1: Placebo: 0.5ml Normal saline injecte

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age between 7 and 18 years Undergoing Renal transplant 2.Both genders

Exclusion criteria

Exclusion criteria: 1.Non consenting Patient or parent 2.Coagulation disorder 3.Allergy to Local Anaesthetics 4.Pre Existing Peripheral neuropathies 5.Failed tracheal extubation

Design outcomes

Primary

Measure	Time frame
1.Time to first requirement of analgesia after tracheal extubationTimepoint: 1st, 2nd ,4th ,6th,12th and 24th hour after extubation	—

Secondary

Measure	Time frame
1.NRS at 1st,2nd,4th,6th,12th and 24th hour postoperatively 2.The total fentanyl consumption throughout postoperative 24 hours 3.Postoperative side effects in the form of hypotension, bradycardia, nausea and vomiting for 24 hours after surgery 4.Patient and parent satisfaction score with analgesia Timepoint: 24 hours	—

Countries

India

Contacts

Public ContactDR. RATISH C

AIIMS NEW DELHI

rashmiramachandran1@gmail.com9811422188

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026